Published in J Med Genet on July 01, 2004
Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss. Eur J Hum Genet (2008) 1.07
The contribution of GJB2 mutations to slight or mild hearing loss in Australian elementary school children. J Med Genet (2006) 0.96
Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30. Neurobiol Dis (2010) 0.96
Dominant Cx26 mutants associated with hearing loss have dominant-negative effects on wild type Cx26. Mol Cell Neurosci (2010) 0.92
A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol (2007) 0.90
EKV mutant connexin 31 associated cell death is mediated by ER stress. Hum Mol Genet (2009) 0.86
Prevalence and audiological features in carriers of GJB2 mutations, c.35delG and c.101T>C (p.M34T), in a UK population study. BMJ Open (2012) 0.86
Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet (2008) 0.81
Spectrum and Frequency of the GJB2 Gene Pathogenic Variants in a Large Cohort of Patients with Hearing Impairment Living in a Subarctic Region of Russia (the Sakha Republic). PLoS One (2016) 0.78
Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31
Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet (2000) 3.39
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Plate tectonics of the Red Sea and East Africa. Nature (1970) 2.64
Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl (1982) 2.59
Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry (2000) 2.52
Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed) (1981) 2.47
Camptodactyly, cleft palate, and club foot. A syndrome showing the autosomal-dominant pattern of inheritance. J Med Genet (1969) 2.41
Reprint request reflexes. Nature (1970) 2.36
Intraoral and pulmonary tuberculosis following dental treatment. Lancet (1982) 2.15
Ankylosing spondylitis and lung fibrosis. Q J Med (1972) 2.09
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol (1996) 2.00
Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78
A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol (1998) 1.76
TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population. Br J Cancer (2010) 1.65
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet (2006) 1.64
Birth size and arterial compliance in young adults. Lancet (2000) 1.63
A novel hearing-loss-related mutation occurring in the GJB2 basal promoter. J Med Genet (2007) 1.62
Sequential embryo scoring as a predictor of aneuploidy in poor-prognosis patients. Reprod Biomed Online (2010) 1.60
The effect of phenobarbitone-induction on vitamin D metabolism. Clin Sci (1972) 1.46
Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses (1992) 1.45
Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet (2001) 1.42
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
Pulmonary aspergillomas treated with corticosteroids. Thorax (1972) 1.37
Single-blind Mazzotti test for onchocerciasis. Lancet (1992) 1.37
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci U S A (2002) 1.36
N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet (1999) 1.35
Fibrosing alveolitis and treatment with sulphasalazine. Gut (1974) 1.35
The community integration measure: development and preliminary validation. Arch Phys Med Rehabil (2001) 1.33
Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer (2008) 1.33
Lung fibrosis and cavitation mimicking tuberculosis. Tubercle (1970) 1.32
PCB and organochlorine pesticides in Canadian human milk--1992. Chemosphere (1995) 1.31
Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. J Gen Virol (1992) 1.28
Occupational asthma due to methyl methacrylate and cyanoacrylates. Thorax (1985) 1.27
Connexin mutations in deafness. Nature (1998) 1.23
ER-Tracker dye and BODIPY-brefeldin A differentiate the endoplasmic reticulum and golgi bodies from the tubular-vacuole system in living hyphae of Pisolithus tinctorius. J Microsc (2000) 1.23
Fast neutron treatment for squamous cell carcinoma. BMJ (1991) 1.22
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods (2001) 1.22
Validity and community utility of the Canadian Occupational Performance Measure. Can J Occup Ther (2000) 1.21
Vitamin D deficiency: a concern in pregnant Asian women. Br J Nutr (1995) 1.21
Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol (2011) 1.17
Wnt-16a, a novel Wnt-16 isoform, which shows differential expression in adult human tissues. Biochem Biophys Res Commun (2000) 1.16
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer (2003) 1.16
Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet (2000) 1.15
Genetic analysis of the connexin-26 M34T variant: identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss. J Med Genet (2001) 1.15
Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol (1991) 1.13
Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol (2007) 1.12
Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. Cancer Res (1996) 1.12
Quantitative fluorescence resonance energy transfer (FRET) measurement with acceptor photobleaching and spectral unmixing. J Microsc (2004) 1.11
Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet (1995) 1.09
Rheumatoid pneumoconiosis. A clinical study. Am Rev Respir Dis (1968) 1.08
The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours. Int J Dev Neurosci (1999) 1.07
Pyopneumothorax in rheumatoid lung disease. Thorax (1966) 1.07
A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest (1985) 1.06
Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol (2001) 1.05
Rheumatoid pneumoconiosis: a study in colliery populations in the East Midlands coalfield. Thorax (1967) 1.05
A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2). J Med Genet (1998) 1.04
Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis (2009) 1.04
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03
Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers (2005) 1.03
Spectrum of dominant mutations in the desmosomal cadherin desmoglein 1, causing the skin disease striate palmoplantar keratoderma. Eur J Hum Genet (2001) 1.03
Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients. Q J Med (1983) 1.02
Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. Am J Hum Genet (1993) 1.02
Determination of PCB metabolites in Canadian human milk. Chemosphere (1996) 1.01
Aberrant gating, but a normal expression pattern, underlies the recessive phenotype of the deafness mutant Connexin26M34T. FASEB J (2004) 1.01
Cultured composite skin grafts for burns. BMJ (1990) 1.01
Segregation of delta F508 and normal CFTR alleles in human sperm. Hum Mol Genet (1993) 1.00
Evaluation of fetal cardiac dysrhythmias with two-dimensional, M-mode, and pulsed Doppler ultrasonography. Am J Obstet Gynecol (1988) 1.00
Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma. Proc Natl Acad Sci U S A (1993) 1.00
Home nebulizers in severe chronic asthma. Br J Dis Chest (1984) 0.99
Skin loss in meningococcal septicaemia. Br J Plast Surg (1980) 0.99
Preferences for different sources of information about cancer. Patient Educ Couns (1999) 0.98
Specific loss of connexin 26 expression in ductal sweat gland epithelium associated with the deletion mutation del(GJB6-D13S1830). Clin Exp Dermatol (2005) 0.98
Structure of an antibody-lysozyme complex unexpected effect of conservative mutation. J Mol Biol (1995) 0.98
Immediate release of crystallographic data: a proposal. Science (1998) 0.98
Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. J Immunol Methods (2001) 0.98
Publishing information about patients. GMC's guidelines should be followed before information is put on Internet. BMJ (1996) 0.97
Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication. Oncogene (2000) 0.97
Pituitary gigantism: a disabling condition. Clin Endocrinol (Oxf) (1982) 0.97
Ultrasound evaluation of tachycardia-induced hydrops in the fetal lamb. Am J Obstet Gynecol (1987) 0.96
Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood (1993) 0.96
BMJ on the internet. Neuroscience on the internet. BMJ (1995) 0.95
Letter: Pleural effusion. Br Med J (1975) 0.95
Disability, survival and coalworkers' pneumoconiosis. Br Med J (1973) 0.95
A novel M163L mutation in connexin 26 causing cell death and associated with autosomal dominant hearing loss. Hear Res (2008) 0.93
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet (2000) 0.93
Riedel's thyroiditis with invasion of the lungs. Thorax (1981) 0.93
Tumor necrosis factor alpha-induced eosinophil accumulation in rat skin is dependent on alpha4 integrin/vascular cell adhesion molecule-1 adhesion pathways. Blood (1997) 0.93
Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med (2000) 0.92
A case of dermatopathia pigmentosa reticularis with wiry scalp hair and digital fibromatosis resulting from a recurrent KRT14 mutation. Clin Exp Dermatol (2008) 0.92
Pulmonary aspergilloma after radiation therapy. Br J Dis Chest (1982) 0.92
Health promotion behaviors of Gujurati Asian Indian immigrants in the United States. J Immigr Health (2000) 0.92
Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis. J Invest Dermatol (1999) 0.91
Separation of peripheral leukocytes by Ficoll density gradient centrifugation. Transplantation (1971) 0.91
Human elastase 1: evidence for expression in the skin and the identification of a frequent frameshift polymorphism. J Invest Dermatol (2000) 0.91
Mica pneumoconiosis. Br J Ind Med (1983) 0.91
Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet (1996) 0.91